Genetic
mutations generally have negative effects, but a recent study has found
that an abnormality in the apoC-III gene could lower a person's risk
of heart disease and improve the breakdown of fat.
Usually, when
genetic mutations are mentioned, people view them in a negative light.
Genetic abnormalities are linked to physical and internal mutations,
vulnerability to certain diseases, defects and deformities, and various
other things that people don't want. However, a recently conducted heart
disease research study found that members of the Old Order Amish community
had a common genetic mutation amongst their members. This mutation was
not entirely bad, though. According to the data obtained, the mutation
actually helped their bodies break down fat in their systems at a faster
rate.
The researchers
determined that the people involved were individuals that had a mutation
that disables two copies of a gene called apoC-III. The code for that
particular protein, APOC3, is known to be responsible for slowing down
the digestion and breakdown of triglycerides in the body. The mutated
gene caused them to break down triglycerides at a rate that was unusually
quick. The gene also appeared to lead to lower levels of LDL cholesterol,
lowering the risk of heart disease. Their arteries also appeared to
be largely clear of plaque, having much less of it present than in the
average person.
The gene in
question was also found to be regulated by insulin, according to data
obtained by heart disease researchers in the University of Pennsylvania.
People with diabetes that had high levels of APOC3 were found to have
higher levels of triglycerides in their system, and an increased risk
of heart disease. The genetic mutation, the researchers believed, would
help bolster the case that triglycerides were related to heart disease,
with APOC3 being an important contributor. However, they acknowledged
that any concrete clinical applications of that knowledge could be years
away from practical use.
The people
that have the genetic mutation appeared to have less cardiovascular
disease, and a much lower risk of it. A study dedicated to clarifying
the role of the gene has begun, though it was known from animal studies
that it might have a role similar to what was observed. The information
for humans was not unexpected, but there were no expectations that there
would be such an implication of it in just one study.